Amarin Corp Plc (AMRN)

[wmjenkins3938]

But, the good thing for Amarin, is the FDA rules start out saying a SPA does not need to be followed if public health is at risk and then follows with the new scientific evidence. Qsymia had severe risks found by Adcomm and was eventually approved with restrictions. Vascepa has no public health concerns, it's all economic, increasing Obamacare care costs, allegedly.